{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:47:52Z","timestamp":1792180072759,"version":"4.4.0"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":79,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82102818"],"award-info":[{"award-number":["82102818"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Qihang Project","award":["SL2024A04J01441"],"award-info":[{"award-number":["SL2024A04J01441"]}]},{"name":"Young Faculty Development Program","award":["24qnpy349"],"award-info":[{"award-number":["24qnpy349"]}]},{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"crossref","award":["2023A1515011600"],"award-info":[{"award-number":["2023A1515011600"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"DOI":"10.1186\/s13062-026-00861-w","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T09:25:20Z","timestamp":1781515520000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Analysis and validation of abnormal signaling pathways and immune cell infiltration characteristics in digestive system cancers based on peroxisome-related genes"],"prefix":"10.1186","volume":"21","author":[{"given":"Jie","family":"Wen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abudureyimujiang","family":"Aili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongliang","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoqing","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haikuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhe","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"issue":"1","key":"861_CR1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41392-024-02097-4","volume":"10","author":"T Zhan","year":"2025","unstructured":"Zhan T, Betge J, Schulte N, Dreikhausen L, Hirth M, Li M, Weidner P, Leipertz A, Teufel A, Ebert MP. Digestive cancers: mechanisms, therapeutics and management. Signal Transduct Target Ther. 2025;10(1):24.","journal-title":"Signal Transduct Target Ther"},{"key":"861_CR2","doi-asserted-by":"publisher","first-page":"107280","DOI":"10.1016\/j.phrs.2024.107280","volume":"206","author":"Z Nian","year":"2024","unstructured":"Nian Z, Deng M, Ye L, Tong X, Xu Y, Xu Y, Chen R, Wang Y, Mao F, Xu C, et al. RNA epigenetic modifications in digestive tract cancers: Friends or foes. Pharmacol Res. 2024;206:107280.","journal-title":"Pharmacol Res"},{"issue":"5","key":"861_CR3","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00418-018-1722-5","volume":"150","author":"M Islinger","year":"2018","unstructured":"Islinger M, Voelkl A, Fahimi HD, Schrader M. The peroxisome: an update on mysteries 2.0. Histochem Cell Biol. 2018;150(5):443\u201371.","journal-title":"Histochem Cell Biol"},{"key":"861_CR4","doi-asserted-by":"publisher","first-page":"102044","DOI":"10.1016\/j.molmet.2024.102044","volume":"90","author":"AM Pratama","year":"2024","unstructured":"Pratama AM, Sharma M, Naidu S, B\u00f6mmel H, Prabhuswamimath SC, Madhusudhan T, Wihadmadyatami H, Bachhuka A, Karnati S. Peroxisomes and PPARs: Emerging role as master regulators of cancer metabolism. Mol Metab. 2024;90:102044.","journal-title":"Mol Metab"},{"issue":"7961","key":"861_CR5","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41586-023-06044-1","volume":"617","author":"R Ravindran","year":"2023","unstructured":"Ravindran R, Bacellar IOL, Castellanos-Girouard X, Wahba HM, Zhang Z, Omichinski JG, Kisley L, Michnick SW. Peroxisome biogenesis initiated by protein phase separation. Nature. 2023;617(7961):608\u201315.","journal-title":"Nature"},{"key":"861_CR6","doi-asserted-by":"crossref","unstructured":"Hongqin Liu, et al. ZBTB17\/MIZ1 promotes peroxisome biogenesis by transcriptional regulation of PEX13. J Cell Biol. 2025;224(6):e202407198.","DOI":"10.1083\/jcb.202407198"},{"key":"861_CR7","doi-asserted-by":"crossref","unstructured":"Kim JA. Peroxisome metabolism in cancer. Cells. 2020;9(7).","DOI":"10.3390\/cells9071692"},{"key":"861_CR8","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.trsl.2018.07.014","volume":"202","author":"B Banoth","year":"2018","unstructured":"Banoth B, Cassel SL. Mitochondria in innate immune signaling. Transl Res. 2018;202:52\u201368.","journal-title":"Transl Res"},{"issue":"10","key":"861_CR9","doi-asserted-by":"publisher","first-page":"101835","DOI":"10.1016\/j.clinre.2021.101835","volume":"46","author":"T Liu","year":"2022","unstructured":"Liu T, Yuan Z, Wang H, Wang J, Xue L. Peroxisome-related genes in hepatocellular carcinoma correlated with tumor metabolism and overall survival. Clin Res Hepatol Gastroenterol. 2022;46(10):101835.","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"12","key":"861_CR10","doi-asserted-by":"publisher","first-page":"5322","DOI":"10.7150\/thno.42371","volume":"10","author":"J Wen","year":"2020","unstructured":"Wen J, Xiong K, Aili A, Wang H, Zhu Y, Yu Z, Yao X, Jiang P, Xue L, Wang J. PEX5, a novel target of microRNA-31-5p, increases radioresistance in hepatocellular carcinoma by activating Wnt\/\u03b2-catenin signaling and homologous recombination. Theranostics. 2020;10(12):5322\u201340.","journal-title":"Theranostics"},{"issue":"10","key":"861_CR11","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1007\/s11427-024-2938-3","volume":"68","author":"Z Yuan","year":"2025","unstructured":"Yuan Z, Liu T, Jiang P, Zhao Y, Guo R, Ye X, He Q, Wang H, Xue L, Wang J. PEX5 deficiency enhances radiosensitivity via MGST1-GSH detoxifying function and promotes ferroptosis in liver cancer. Sci China Life Sci. 2025;68(10):2908\u201322.","journal-title":"Sci China Life Sci"},{"key":"861_CR12","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.canlet.2018.02.021","volume":"421","author":"M Cai","year":"2018","unstructured":"Cai M, Sun X, Wang W, Lian Z, Wu P, Han S, Chen H, Zhang P. Disruption of peroxisome function leads to metabolic stress, mTOR inhibition, and lethality in liver cancer cells. Cancer Lett. 2018;421:82\u201393.","journal-title":"Cancer Lett"},{"issue":"1","key":"861_CR13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12885-021-09085-9","volume":"22","author":"J Yin","year":"2022","unstructured":"Yin J, Wang H, Hong Y, Ren A, Wang H, Liu L, Zhao Q. Identification of an at-risk subpopulation with high immune infiltration based on the peroxisome pathway and TIM3 in colorectal cancer. BMC Cancer. 2022;22(1):44.","journal-title":"BMC Cancer"},{"issue":"1","key":"861_CR14","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41419-025-07572-6","volume":"16","author":"J Yin","year":"2025","unstructured":"Yin J, Shao Y, Huang F, Hong Y, Wei W, Jiang C, Zhao Q, Liu L. Peroxisomal membrane protein PMP70 confers drug resistance in colorectal cancer. Cell Death Dis. 2025;16(1):293.","journal-title":"Cell Death Dis"},{"issue":"1","key":"861_CR15","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s10620-023-08168-w","volume":"69","author":"B Yan","year":"2024","unstructured":"Yan B, Cao L, Gao L, Wei S, Wang M, Tian Y, Yang J, Chen E. PEX26 Functions as a Metastasis Suppressor in Colorectal Cancer. Dig Dis Sci. 2024;69(1):112\u201322.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"861_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12575-025-00289-y","volume":"27","author":"Y Hepei","year":"2025","unstructured":"Hepei Y, Jun Z, Muhammad K, Baiyao W, Xiaoshan H, Hao W, Zhaotong W, Yawei Y. FNDC5 and ACOX1 as Biomarkers of Peroxisomal Activity with Contrast Outcomes in Colon Adenocarcinoma. Biol Proced Online. 2025;27(1):27.","journal-title":"Biol Proced Online"},{"key":"861_CR17","doi-asserted-by":"publisher","first-page":"683241","DOI":"10.3389\/fonc.2021.683241","volume":"11","author":"X Wu","year":"2021","unstructured":"Wu X, Wang Z, Jiang Y, Zhou H, Li A, Wei Y, Bao Z, Wang D, Zhao J, Chen X, et al. Tegaserod Maleate Inhibits Esophageal Squamous Cell Carcinoma Proliferation by Suppressing the Peroxisome Pathway. Front Oncol. 2021;11:683241.","journal-title":"Front Oncol"},{"issue":"3","key":"861_CR18","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.ajpath.2024.07.023","volume":"195","author":"I Cheon","year":"2025","unstructured":"Cheon I, Kim M, Kim KH, Ko S. Hepatic Nuclear Receptors in Cholestasis-to-Cholangiocarcinoma Pathology. Am J Pathol. 2025;195(3):409\u201321.","journal-title":"Am J Pathol"},{"issue":"1","key":"861_CR19","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.gendis.2020.04.010","volume":"9","author":"L Qiu","year":"2022","unstructured":"Qiu L, Zhan K, Malale K, Wu X, Mei Z. Transcriptomic profiling of peroxisome-related genes reveals a novel prognostic signature in hepatocellular carcinoma. Genes Dis. 2022;9(1):116\u201327.","journal-title":"Genes Dis"},{"issue":"6","key":"861_CR20","doi-asserted-by":"publisher","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","volume":"8","author":"C Kilkenny","year":"2010","unstructured":"Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 2010;8(6):e1000412.","journal-title":"PLoS Biol"},{"issue":"7869","key":"861_CR21","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/s41586-021-03741-7","volume":"595","author":"H Jin","year":"2021","unstructured":"Jin H, Shi Y, Lv Y, Yuan S, Ramirez CFA, Lieftink C, Wang L, Wang S, Wang C, Dias MH, et al. EGFR activation limits the response of liver cancer to lenvatinib. Nature. 2021;595(7869):730\u20134.","journal-title":"Nature"},{"issue":"2","key":"861_CR22","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1006\/rtph.2002.1575","volume":"36","author":"W Kaufmann","year":"2002","unstructured":"Kaufmann W, Deckardt K, McKee RH, Butala JH, Bahnemann R. Tumor induction in mouse liver: di-isononyl phthalate acts via peroxisome proliferation. Regul Toxicol Pharmacol. 2002;36(2):175\u201383.","journal-title":"Regul Toxicol Pharmacol"},{"issue":"1","key":"861_CR23","doi-asserted-by":"publisher","first-page":"5945","DOI":"10.1038\/s41467-022-33493-5","volume":"13","author":"C Ge","year":"2022","unstructured":"Ge C, Tan J, Dai X, Kuang Q, Zhong S, Lai L, Yi C, Sun Y, Luo J, Zhang C, et al. Hepatocyte phosphatase DUSP22 mitigates NASH-HCC progression by targeting FAK. Nat Commun. 2022;13(1):5945.","journal-title":"Nat Commun"},{"issue":"21","key":"861_CR24","doi-asserted-by":"publisher","first-page":"14190","DOI":"10.1074\/jbc.M800402200","volume":"283","author":"CP Grou","year":"2008","unstructured":"Grou CP, Carvalho AF, Pinto MP, Wiese S, Piechura H, Meyer HE, Warscheid B, S\u00e1-Miranda C, Azevedo JE. Members of the E2D (UbcH5) family mediate the ubiquitination of the conserved cysteine of Pex5p, the peroxisomal import receptor. J Biol Chem. 2008;283(21):14190\u20137.","journal-title":"J Biol Chem"},{"issue":"1","key":"861_CR25","doi-asserted-by":"publisher","first-page":"7348","DOI":"10.1038\/s41467-023-43262-7","volume":"14","author":"LC Hunt","year":"2023","unstructured":"Hunt LC, Pagala V, Stephan A, Xie B, Kodali K, Kavdia K, Wang YD, Shirinifard A, Curley M, Graca FA, et al. An adaptive stress response that confers cellular resilience to decreased ubiquitination. Nat Commun. 2023;14(1):7348.","journal-title":"Nat Commun"},{"issue":"1","key":"861_CR26","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41392-020-00404-3","volume":"5","author":"D Tang","year":"2020","unstructured":"Tang D, Kroemer G. Peroxisome: the new player in ferroptosis. Signal Transduct Target Ther. 2020;5(1):273.","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"861_CR27","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1038\/s41416-023-02557-8","volume":"130","author":"CY Mah","year":"2024","unstructured":"Mah CY, Nguyen ADT, Niijima T, Helm M, Dehairs J, Ryan FJ, Ryan N, Quek LE, Hoy AJ, Don AS, et al. Peroxisomal \u03b2-oxidation enzyme, DECR2, regulates lipid metabolism and promotes treatment resistance in advanced prostate cancer. Br J Cancer. 2024;130(5):741\u201354.","journal-title":"Br J Cancer"},{"key":"861_CR28","doi-asserted-by":"publisher","first-page":"1814232","DOI":"10.3389\/fcell.2026.1814232","volume":"14","author":"B Li","year":"2026","unstructured":"Li B, Cui Z, Jin Y. The multifaceted roles of mesenchymal stem cell-derived exosomes in digestive system malignancies: mechanisms and therapeutic implications. Front Cell Dev Biol. 2026;14:1814232.","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"861_CR29","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.cld.2018.06.002","volume":"22","author":"KR Mysore","year":"2018","unstructured":"Mysore KR, Leung DH. Hepatitis B and C. Clin Liver Dis. 2018;22(4):703\u201322.","journal-title":"Clin Liver Dis"},{"issue":"2","key":"861_CR30","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s00103-021-03482-y","volume":"65","author":"M Glitscher","year":"2022","unstructured":"Glitscher M, Hildt E, Bender D. [Hepatitis B and C: mechanisms of virus-induced liver pathogenesis and tumorigenesis]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2022;65(2):228\u201337.","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"861_CR31","doi-asserted-by":"publisher","first-page":"111183","DOI":"10.1016\/j.cellsig.2024.111183","volume":"119","author":"F Shi","year":"2024","unstructured":"Shi F, Jiang J, Wang B, Hong L, Zhang Y, Meng Y, Zhang X, Gong L, Lin J, Diao H. Hepatitis B virus X protein promotes tumor glycolysis by downregulating lncRNA OIP5-AS1\/HKDC1 in HCC. Cell Signal. 2024;119:111183.","journal-title":"Cell Signal"},{"issue":"1","key":"861_CR32","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s12672-025-02295-8","volume":"16","author":"F Chen","year":"2025","unstructured":"Chen F, Cai Y, Zhou J. Relationship between retinol metabolism and hepatocellular carcinoma: a comprehensive analysis of Mendelian randomization, prognostic characteristic and experiment. Discov Oncol. 2025;16(1):513.","journal-title":"Discov Oncol"},{"issue":"4","key":"861_CR33","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1097\/HEP.0000000000000962","volume":"81","author":"Q Liu","year":"2025","unstructured":"Liu Q, Zhang X, Qi J, Tian X, Dovjak E, Zhang J, Du H, Zhang N, Zhao J, Zhang Y, et al. Comprehensive profiling of lipid metabolic reprogramming expands precision medicine for HCC. Hepatology. 2025;81(4):1164\u201380.","journal-title":"Hepatology"},{"key":"861_CR34","doi-asserted-by":"publisher","first-page":"122905","DOI":"10.1016\/j.lfs.2024.122905","volume":"352","author":"Q Cao","year":"2024","unstructured":"Cao Q, Gao Y, Zhou C, Yan Y, Yu J, Wang P, Zhang B, Sun L. Intervention of epithelial mesenchymal transition against colon cancer cell growth and metastasis based on SOX21\/POU4F2\/Hedgehog signaling axis. Life Sci. 2024;352:122905.","journal-title":"Life Sci"},{"issue":"4","key":"861_CR35","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.7150\/ijbs.102742","volume":"21","author":"Y Chen","year":"2025","unstructured":"Chen Y, Qin Y, Fan T, Qiu C, Zhang Y, Dai M, Zhou Y, Sun Q, Guo Y, Hao Y, et al. Solobacterium moorei promotes tumor progression via the Integrin \u03b12\/\u03b21-PI3K-AKT-mTOR-C-myc signaling pathway in colorectal cancer. Int J Biol Sci. 2025;21(4):1497\u2013512.","journal-title":"Int J Biol Sci"},{"key":"861_CR36","doi-asserted-by":"crossref","unstructured":"Luo LZ, Kim JH, Herrera I, Wu S, Wu X, Park SS, Cho J, Cope L, Xian L, West BE, et al. HMGA1 acts as an epigenetic gatekeeper of ASCL2 and Wnt signaling during colon tumorigenesis. J Clin Invest. 2025;135(3).","DOI":"10.1172\/JCI184442"},{"issue":"1","key":"861_CR37","doi-asserted-by":"publisher","first-page":"2350149","DOI":"10.1080\/19490976.2024.2350149","volume":"16","author":"WP Duggan","year":"2024","unstructured":"Duggan WP, Kisakol B, Woods I, Azimi M, Dussmann H, Fay J, O\u2019Grady T, Maguire B, Reynolds IS, Salvucci M, et al. Spatial transcriptomic analysis reveals local effects of intratumoral fusobacterial infection on DNA damage and immune signaling in rectal cancer. Gut Microbes. 2024;16(1):2350149.","journal-title":"Gut Microbes"},{"key":"861_CR38","doi-asserted-by":"publisher","unstructured":"Hasegawa K, Sakamaki Y, Tamaki M, Wakino S. Voclosporin overdose-induced peroxisomal structural changes and AKI are prevented by renal indole detoxifier, INMT. J Am Soc Nephrol. 2025; 36(11):2103\u201319 https:\/\/doi.org\/10.1681\/ASN.0000000751.","DOI":"10.1681\/ASN.0000000751"},{"issue":"5","key":"861_CR39","doi-asserted-by":"publisher","first-page":"112413","DOI":"10.1016\/j.isci.2025.112413","volume":"28","author":"A Iannucci","year":"2025","unstructured":"Iannucci A, Lacarbonara D, Caneparo V, Castiglioni F, Buttic\u00e8 A, Raviola S, Porta C, Miggiano R, Zanoni I, Gariglio M, et al. The PYRIN domain is required for TLR4-mediated inflammation by PYHIN family members. iScience. 2025;28(5):112413.","journal-title":"iScience"},{"issue":"5","key":"861_CR40","doi-asserted-by":"publisher","first-page":"167761","DOI":"10.1016\/j.bbadis.2025.167761","volume":"1871","author":"C Parolini","year":"2025","unstructured":"Parolini C. Sepsis and high-density lipoproteins: Pathophysiology and potential new therapeutic targets. Biochim Biophys Acta Mol Basis Dis. 2025;1871(5):167761.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"1","key":"861_CR41","doi-asserted-by":"publisher","first-page":"2512035","DOI":"10.1080\/21505594.2025.2512035","volume":"16","author":"B Seo","year":"2025","unstructured":"Seo B, Lim MY. Balancing harm and harmony: Evolutionary dynamics between gut microbiota-derived flagellin and TLR5-mediated host immunity and metabolism. Virulence. 2025;16(1):2512035.","journal-title":"Virulence"},{"key":"861_CR42","doi-asserted-by":"publisher","unstructured":"Kuchitsu Y, Taguchi T. Innate immune signals triggered on organelle membranes. J Biochem. 2025;178(2):145 https:\/\/doi.org\/10.1093\/jb\/mvaf016","DOI":"10.1093\/jb\/mvaf016"},{"issue":"1","key":"861_CR43","doi-asserted-by":"publisher","first-page":"2509483","DOI":"10.1080\/21645515.2025.2509483","volume":"21","author":"Z Song","year":"2025","unstructured":"Song Z, Yang C, Gu J, Qu R, Xie Y, Guo Y, Nong X, Chen Z, Wang Z. The hotspots and publication trends in glioblastoma and CAR-T immunotherapy: A bibliometric analysis. Hum Vaccin Immunother. 2025;21(1):2509483.","journal-title":"Hum Vaccin Immunother"},{"issue":"17","key":"861_CR44","doi-asserted-by":"publisher","first-page":"5828","DOI":"10.7150\/jca.94573","volume":"15","author":"M Wei","year":"2024","unstructured":"Wei M, Yang X, Yang X, Huang Y, Yuan Z, Huang J, Wei J, Tian L. MLPH regulates EMT in pancreatic adenocarcinoma through the PI3K-AKT signaling pathway. J Cancer. 2024;15(17):5828\u201338.","journal-title":"J Cancer"},{"key":"861_CR45","doi-asserted-by":"publisher","first-page":"216806","DOI":"10.1016\/j.canlet.2024.216806","volume":"588","author":"H Huang","year":"2024","unstructured":"Huang H, Wang S, Xia H, Zhao X, Chen K, Jin G, Zhou S, Lu Z, Chen T, Yu H, et al. Lactate enhances NMNAT1 lactylation to sustain nuclear NAD(+) salvage pathway and promote survival of pancreatic adenocarcinoma cells under glucose-deprived conditions. Cancer Lett. 2024;588:216806.","journal-title":"Cancer Lett"},{"issue":"1","key":"861_CR46","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1186\/s12885-024-13180-y","volume":"24","author":"J Dou","year":"2024","unstructured":"Dou J, Hu W, Zhang X, Jiang K. NOP10 predicts poor prognosis and promotes pancreatic cancer progression. BMC Cancer. 2024;24(1):1394.","journal-title":"BMC Cancer"},{"issue":"2","key":"861_CR47","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s40291-024-00755-5","volume":"29","author":"RD Houvast","year":"2025","unstructured":"Houvast RD, van Duijvenvoorde M, Thijse K, de Steur WO, de Geus-Oei LF, Crobach A, Burggraaf J, Vahrmeijer AL, Kuppen PJK. Selecting Targets for Molecular Imaging of Gastric Cancer: An Immunohistochemical Evaluation. Mol Diagn Ther. 2025;29(2):213\u201327.","journal-title":"Mol Diagn Ther"},{"issue":"1","key":"861_CR48","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s43046-022-00108-5","volume":"34","author":"RJ Sarma","year":"2022","unstructured":"Sarma RJ, Subbarayan S, Zohmingthanga J, Chenkual S, Zomuana T, Lalruatfela ST, Pautu JL, Maitra A, Kumar NS. Transcriptome analysis reveals SALL4 as a prognostic key gene in gastric adenocarcinoma. J Egypt Natl Canc Inst. 2022;34(1):11.","journal-title":"J Egypt Natl Canc Inst"},{"issue":"19","key":"861_CR49","doi-asserted-by":"publisher","first-page":"6703","DOI":"10.1158\/1078-0432.CCR-04-0838","volume":"10","author":"X Chen","year":"2004","unstructured":"Chen X, Wang S, Wu N, Sood S, Wang P, Jin Z, Beer DG, Giordano TJ, Lin Y, Shih WC, et al. Overexpression of 5-lipoxygenase in rat and human esophageal adenocarcinoma and inhibitory effects of zileuton and celecoxib on carcinogenesis. Clin Cancer Res. 2004;10(19):6703\u20139.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"861_CR50","doi-asserted-by":"publisher","first-page":"e810","DOI":"10.1002\/ctm2.810","volume":"12","author":"J Molendijk","year":"2022","unstructured":"Molendijk J, Kolka CM, Cairns H, Brosda S, Mohamed A, Shah AK, Brown I, Hodson MP, Hennessy T, Liu G, et al. Elevation of fatty acid desaturase 2 in esophageal adenocarcinoma increases polyunsaturated lipids and may exacerbate bile acid-induced DNA damage. Clin Transl Med. 2022;12(5):e810.","journal-title":"Clin Transl Med"},{"issue":"6","key":"861_CR51","doi-asserted-by":"publisher","first-page":"431","DOI":"10.2174\/0113894501265851240102101122","volume":"25","author":"Y Zhuang","year":"2024","unstructured":"Zhuang Y, Sun YG, Wang CG, Zhang Q, Che C, Shao F. Molecular Targets and Mechanisms of Hedyotis diffusa Willd. for Esophageal Adenocarcinoma Treatment Based on Network Pharmacology and Weighted Gene Co-expression Network Analysis. Curr Drug Targets. 2024;25(6):431\u201343.","journal-title":"Curr Drug Targets"},{"issue":"1\u20132","key":"861_CR52","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.prostaglandins.2010.12.001","volume":"94","author":"M Schmelzle","year":"2011","unstructured":"Schmelzle M, Dizdar L, Matthaei H, Baldus SE, Wolters J, Lindenlauf N, Bruns I, Cadeddu RP, Kr\u00f6pil F, Topp SA, et al. Esophageal cancer proliferation is mediated by cytochrome P450 2C9 (CYP2C9). Prostaglandins Other Lipid Mediat. 2011;94(1\u20132):25\u201333.","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"2","key":"861_CR53","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/mc.23273","volume":"60","author":"L Zhang","year":"2021","unstructured":"Zhang L, Zhao D, Wang Y, Zhang W, Zhang J, Fan J, Zhan Q, Chen J. Focal adhesion kinase (FAK) inhibitor-defactinib suppresses the malignant progression of human esophageal squamous cell carcinoma (ESCC) cells via effective blockade of PI3K\/AKT axis and downstream molecular network. Mol Carcinog. 2021;60(2):113\u201324.","journal-title":"Mol Carcinog"},{"issue":"4","key":"861_CR54","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.62347\/OGMW9514","volume":"15","author":"M Yao","year":"2025","unstructured":"Yao M, Xie Y, Huang M, Han X, Zhou Y, Tao M, Liu C, Zhao Y, Zhang C, Gao Y. PSPH promotes the proliferation and metastasis of esophageal squamous cell carcinoma through MAPK signaling pathways. Am J Cancer Res. 2025;15(4):1919\u201331.","journal-title":"Am J Cancer Res"},{"issue":"5","key":"861_CR55","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.3892\/mmr.2015.3216","volume":"11","author":"J Wu","year":"2015","unstructured":"Wu J, Xiao Z, Zhao X, Wu X. Revealing gene clusters associated with the development of cholangiocarcinoma, based on a time series analysis. Mol Med Rep. 2015;11(5):3481\u20136.","journal-title":"Mol Med Rep"},{"issue":"6","key":"861_CR56","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1007\/s12094-024-03797-7","volume":"27","author":"Y Yang","year":"2025","unstructured":"Yang Y, Li Q, Chu LT, Lin X, Chen H, Chen L, Tang J, Zeng T. Autophagy in cholangiocarcinoma: a comprehensive review about roles and regulatory mechanisms. Clin Transl Oncol. 2025;27(6):2391\u2013400.","journal-title":"Clin Transl Oncol"},{"key":"861_CR57","doi-asserted-by":"crossref","unstructured":"Li M, Cui P, Dai W, Cao B, Zhao H, Jin S, Xu D, Shi Y, Yan S. S100 protein family: Emerging role and mechanism in digestive tract cancer (Review). Int J Oncol. 2024;64(6).","DOI":"10.3892\/ijo.2024.5647"},{"issue":"10","key":"861_CR58","first-page":"1955","volume":"62","author":"P Wang","year":"2016","unstructured":"Wang P, Li W, Peng J, Qi S, Song L, Liu C, Li F. Clinicopathological Significance of RhoA Expression in Digestive Tract Cancer: A Systematic Review and Meta-Analysis. Clin Lab. 2016;62(10):1955\u201364.","journal-title":"Clin Lab"},{"key":"861_CR59","doi-asserted-by":"publisher","first-page":"1595850","DOI":"10.3389\/fimmu.2025.1595850","volume":"16","author":"L Huang","year":"2025","unstructured":"Huang L, Li X, Huang S, Jiang Q, Jiang C, He W, Cai Y, Guo G. Comprehensive analysis of the functional and immunological significance of ETV4 in pan-cancer and its validation in digestive tumors. Front Immunol. 2025;16:1595850.","journal-title":"Front Immunol"},{"key":"861_CR60","doi-asserted-by":"crossref","unstructured":"Auwercx J, Rybarczyk P, Kischel P, Dhennin-Duthille I, Chatelain D, Sevestre H, Van Seuningen I, Ouadid-Ahidouch H, Jonckheere N, Gautier M. Mg(2+) transporters in digestive cancers. Nutrients. 2021;13(1).","DOI":"10.3390\/nu13010210"},{"key":"861_CR61","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.semcancer.2017.09.009","volume":"50","author":"F Shi","year":"2018","unstructured":"Shi F, Li T, Liu Z, Qu K, Shi C, Li Y, Qin Q, Cheng L, Jin X, Yu T, et al. FOXO1: Another avenue for treating digestive malignancy? Semin Cancer Biol. 2018;50:124\u201331.","journal-title":"Semin Cancer Biol"},{"issue":"12","key":"861_CR62","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/s41419-020-03245-8","volume":"11","author":"N Christou","year":"2020","unstructured":"Christou N, Blondy S, David V, Verdier M, Lallou\u00e9 F, Jauberteau MO, Mathonnet M, Perraud A. Neurotensin pathway in digestive cancers and clinical applications: an overview. Cell Death Dis. 2020;11(12):1027.","journal-title":"Cell Death Dis"},{"key":"861_CR63","doi-asserted-by":"publisher","first-page":"153303382097328","DOI":"10.1177\/1533033820973280","volume":"19","author":"C Tian","year":"2020","unstructured":"Tian C, Chen K, Gong W, Yoshimura T, Huang J, Wang JM. The G-Protein Coupled Formyl Peptide Receptors and Their Role in the Progression of Digestive Tract Cancer. Technol Cancer Res Treat. 2020;19:1533033820973280.","journal-title":"Technol Cancer Res Treat"},{"issue":"6","key":"861_CR64","doi-asserted-by":"publisher","first-page":"e39482","DOI":"10.1371\/journal.pone.0039482","volume":"7","author":"HJ Kim","year":"2012","unstructured":"Kim HJ, Hwang SH, Han ME, Baek S, Sim HE, Yoon S, Baek SY, Kim BS, Kim JH, Kim SY, et al. LAP2 is widely overexpressed in diverse digestive tract cancers and regulates motility of cancer cells. PLoS ONE. 2012;7(6):e39482.","journal-title":"PLoS ONE"},{"issue":"5","key":"861_CR65","doi-asserted-by":"publisher","first-page":"4705","DOI":"10.1007\/s00210-024-03661-z","volume":"398","author":"G Ranjan","year":"2025","unstructured":"Ranjan G, Ranjan S, Sunita P, Pattanayak SP. Thiazolidinedione derivatives in cancer therapy: exploring novel mechanisms, therapeutic potentials, and future horizons in oncology. Naunyn Schmiedebergs Arch Pharmacol. 2025;398(5):4705\u201325.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"861_CR66","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12575-025-00281-6","volume":"27","author":"Y Zou","year":"2025","unstructured":"Zou Y, Wan X, Zhou Q, Zhu G, Lin S, Tang Q, Yang X, Wang S. Mechanisms of drug resistance in hepatocellular carcinoma. Biol Proced Online. 2025;27(1):19.","journal-title":"Biol Proced Online"},{"key":"861_CR67","doi-asserted-by":"publisher","first-page":"104773","DOI":"10.1016\/j.critrevonc.2025.104773","volume":"213","author":"J Yang","year":"2025","unstructured":"Yang J, Chen R. Radiosensitization strategies for hepatocellular carcinoma: Mechanisms, therapeutic advances, and clinical perspectives. Crit Rev Oncol Hematol. 2025;213:104773.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"861_CR68","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s12035-012-8259-8","volume":"46","author":"YC Chen","year":"2012","unstructured":"Chen YC, Wu JS, Tsai HD, Huang CY, Chen JJ, Sun GY, Lin TN. Peroxisome proliferator-activated receptor gamma (PPAR-\u03b3) and neurodegenerative disorders. Mol Neurobiol. 2012;46(1):114\u201324.","journal-title":"Mol Neurobiol"},{"issue":"9","key":"861_CR69","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nri.2016.70","volume":"16","author":"LA O\u2019Neill","year":"2016","unstructured":"O\u2019Neill LA, Kishton RJ, Rathmell J. A guide to immunometabolism for immunologists. Nat Rev Immunol. 2016;16(9):553\u201365.","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"861_CR70","doi-asserted-by":"publisher","first-page":"893","DOI":"10.2174\/1381612043452893","volume":"10","author":"O Harari","year":"2004","unstructured":"Harari O, Liao JK. Inhibition of MHC II gene transcription by nitric oxide and antioxidants. Curr Pharm Des. 2004;10(8):893\u20138.","journal-title":"Curr Pharm Des"},{"issue":"4","key":"861_CR71","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.jhep.2025.03.035","volume":"83","author":"T Cui","year":"2025","unstructured":"Cui T, Sun L, Guo X, Cheng C, Zhang N, Zhou S, Chu Q, Xing C, Liang S, Liu Y, et al. Tumor-derived CD109 orchestrates reprogramming of tumor-associated macrophages to dampen immune response. J Hepatol. 2025;83(4):946\u201358.","journal-title":"J Hepatol"},{"key":"861_CR72","doi-asserted-by":"publisher","first-page":"156273","DOI":"10.1016\/j.metabol.2025.156273","volume":"169","author":"Y Lu","year":"2025","unstructured":"Lu Y, Chen L, Lin Y, Zhang Y, Wang Y, Yu W, Ren F, Guo H. Fatty acid metabolism: The crossroads in intestinal homeostasis and tumor. Metabolism. 2025;169:156273.","journal-title":"Metabolism"},{"key":"861_CR73","doi-asserted-by":"crossref","unstructured":"Rakhshandehroo M, Knoch B, M\u00fcller M, Kersten S. Peroxisome proliferator-activated receptor alpha target genes. PPAR Res. 2010;2010.","DOI":"10.1155\/2010\/612089"},{"issue":"2","key":"861_CR74","first-page":"159","volume":"448","author":"AV Yeldandi","year":"2000","unstructured":"Yeldandi AV, Rao MS, Reddy JK. Hydrogen peroxide generation in peroxisome proliferator-induced oncogenesis. Mutat Res. 2000;448(2):159\u201377.","journal-title":"Mutat Res"},{"key":"861_CR75","doi-asserted-by":"publisher","unstructured":"Wehbe M, Zalzal RN, El-Khoury R, Charafeddine L, Karam PE. Mitochondria and peroxisome crosstalk in peroxisome biogenesis disorder 8A caused by a rare variant in PEX16 gene. Clin Genet 2025;108(4):463\u20137. https:\/\/doi.org\/10.1111\/cge.14753.","DOI":"10.1111\/cge.14753"},{"issue":"14","key":"861_CR76","doi-asserted-by":"publisher","first-page":"e18533","DOI":"10.1111\/jcmm.18533","volume":"28","author":"J Lee","year":"2024","unstructured":"Lee J, Kim J, Lee R, Lee E, An HI, Kwon YJ, Jin H, Pack CG, Kim I, Yoon YI, et al. SOD1 inhibition enhances sorafenib efficacy in HBV-related hepatocellular carcinoma by modulating PI3K\/Akt\/mTOR pathway and ROS-mediated cell death. J Cell Mol Med. 2024;28(14):e18533.","journal-title":"J Cell Mol Med"},{"issue":"6","key":"861_CR77","doi-asserted-by":"publisher","first-page":"e70356","DOI":"10.1002\/jbt.70356","volume":"39","author":"H Wang","year":"2025","unstructured":"Wang H, Cui W. RNA-Binding Protein DHX9 Enhances Radioresistance in Metastatic Hepatocellular Carcinoma by Activation of the PI3K\/Akt Pathway Through Enhanced EEF1A2 mRNA Stability. J Biochem Mol Toxicol. 2025;39(6):e70356.","journal-title":"J Biochem Mol Toxicol"},{"key":"861_CR78","doi-asserted-by":"crossref","unstructured":"Liu J, Zhang Y, Ran W, Yang L, Zhang W, Liu Z. Mechanisms of tumor heterogeneity in TACE-resistant liver cancer: insights from single-cell and whole-exome sequencing. Hepatol Commun. 2025;9(7).","DOI":"10.1097\/HC9.0000000000000705"},{"issue":"2","key":"861_CR79","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1046\/j.1523-1747.1999.00487.x","volume":"112","author":"RL Rosenfield","year":"1999","unstructured":"Rosenfield RL, Kentsis A, Deplewski D, Ciletti N. Rat preputial sebocyte differentiation involves peroxisome proliferator-activated receptors. J Invest Dermatol. 1999;112(2):226\u201332.","journal-title":"J Invest Dermatol"},{"issue":"9","key":"861_CR80","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s11745-003-1149-y","volume":"38","author":"L Bretillon","year":"2003","unstructured":"Bretillon L, Alexson SE, Joffre F, Pasquis B, S\u00e9b\u00e9dio JL. Peroxisome proliferator-activated receptor alpha is not the exclusive mediator of the effects of dietary cyclic FA in mice. Lipids. 2003;38(9):957\u201363.","journal-title":"Lipids"},{"issue":"1","key":"861_CR81","doi-asserted-by":"publisher","first-page":"13485","DOI":"10.1038\/s41598-017-14081-w","volume":"7","author":"J P\u00e9rez-Schindler","year":"2017","unstructured":"P\u00e9rez-Schindler J, Kanhere A, Edwards L, Allwood JW, Dunn WB, Schenk S, Philp A. Exercise and high-fat feeding remodel transcript-metabolite interactive networks in mouse skeletal muscle. Sci Rep. 2017;7(1):13485.","journal-title":"Sci Rep"},{"issue":"45","key":"861_CR82","doi-asserted-by":"publisher","first-page":"4377","DOI":"10.1038\/s41388-025-03581-z","volume":"44","author":"J Li","year":"2025","unstructured":"Li J, Mao S, Yang S, Lou Y, Zhao X, Chen J, Bu Y, Lv B, Shi Q, Zhang Y, et al. Targeting JMJD6\/PPAR\u03b3\/GPX4 axis overcomes ferroptosis resistance and enhances therapeutic efficacy in hepatocellular carcinoma. Oncogene. 2025;44(45):4377\u201390.","journal-title":"Oncogene"},{"issue":"8","key":"861_CR83","doi-asserted-by":"publisher","first-page":"e73038","DOI":"10.1371\/journal.pone.0073038","volume":"8","author":"L Liu","year":"2013","unstructured":"Liu L, Yang Z, Xu Y, Li J, Xu D, Zhang L, Sun J, Xia S, Zou F, Liu Y. Inhibition of oxidative stress-elicited AKT activation facilitates PPAR\u03b3 agonist-mediated inhibition of stem cell character and tumor growth of liver cancer cells. PLoS ONE. 2013;8(8):e73038.","journal-title":"PLoS ONE"},{"issue":"10","key":"861_CR84","doi-asserted-by":"publisher","first-page":"9536","DOI":"10.1074\/jbc.M414067200","volume":"280","author":"WH Faour","year":"2005","unstructured":"Faour WH, Alaaeddine N, Mancini A, He QW, Jovanovic D, Di Battista JA. Early growth response factor-1 mediates prostaglandin E2-dependent transcriptional suppression of cytokine-induced tumor necrosis factor-alpha gene expression in human macrophages and rheumatoid arthritis-affected synovial fibroblasts. J Biol Chem. 2005;280(10):9536\u201346.","journal-title":"J Biol Chem"},{"key":"861_CR85","doi-asserted-by":"publisher","first-page":"740","DOI":"10.3389\/fimmu.2017.00740","volume":"8","author":"DS Coutinho","year":"2017","unstructured":"Coutinho DS, Anjos-Valotta EA, do Nascimento C, Pires ALA, Napimoga MH, Carvalho VF, Torres RC, PMR ES, Martins MA. 15-Deoxy-Delta-12,14-Prostaglandin J(2) Inhibits Lung Inflammation and Remodeling in Distinct Murine Models of Asthma. Front Immunol. 2017;8:740.","journal-title":"Front Immunol"},{"issue":"3","key":"861_CR86","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.bbrc.2010.03.049","volume":"394","author":"Y Kihara","year":"2010","unstructured":"Kihara Y, Yokomizo T, Kunita A, Morishita Y, Fukayama M, Ishii S, Shimizu T. The leukotriene B4 receptor, BLT1, is required for the induction of experimental autoimmune encephalomyelitis. Biochem Biophys Res Commun. 2010;394(3):673\u20138.","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"861_CR87","doi-asserted-by":"publisher","first-page":"11315","DOI":"10.1002\/cam4.5841","volume":"12","author":"X Zou","year":"2023","unstructured":"Zou X, Xu Q, You R, Yin G. Correlation and efficacy of TACE combined with lenvatinib plus PD-1 inhibitor in the treatment of hepatocellular carcinoma with portal vein tumor thrombus based on immunological features. Cancer Med. 2023;12(10):11315\u201333.","journal-title":"Cancer Med"},{"key":"861_CR88","doi-asserted-by":"publisher","first-page":"153380","DOI":"10.1016\/j.bbrc.2026.153380","volume":"805","author":"W Wang","year":"2026","unstructured":"Wang W, Zhao Y, Li M, Wei M, Wu L, Wei J. Deep learning predicts and in vitro experiments validates the synergistic anti-liver cancer effect of vincristine and lenvatinib: Mechanism involving apoptosis induction via the TNF-\u03b1\/Caspase-8 pathway. Biochem Biophys Res Commun. 2026;805:153380.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"861_CR89","doi-asserted-by":"publisher","first-page":"8802","DOI":"10.1038\/s41467-024-52867-5","volume":"15","author":"GK Atkin-Smith","year":"2024","unstructured":"Atkin-Smith GK, Santavanond JP, Light A, Rimes JS, Samson AL, Er J, Liu J, Johnson DN, Le Page M, Rajasekhar P, et al. In situ visualization of endothelial cell-derived extracellular vesicle formation in steady state and malignant conditions. Nat Commun. 2024;15(1):8802.","journal-title":"Nat Commun"},{"issue":"6","key":"861_CR90","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.immuni.2007.11.011","volume":"27","author":"N Kobayashi","year":"2007","unstructured":"Kobayashi N, Karisola P, Pe\u00f1a-Cruz V, Dorfman DM, Jinushi M, Umetsu SE, Butte MJ, Nagumo H, Chernova I, Zhu B, et al. TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells. Immunity. 2007;27(6):927\u201340.","journal-title":"Immunity"},{"issue":"Pt 3","key":"861_CR91","doi-asserted-by":"publisher","first-page":"113514","DOI":"10.1016\/j.intimp.2024.113514","volume":"143","author":"Y Jin","year":"2024","unstructured":"Jin Y, Wang Y, Feng M, Ni X, Qiang L, Xue J, Sun L, Gao C, Luo J. Sphingosine-1-phosphate alleviates Sj\u00f6gren\u2019s syndrome-like symptoms via inducing autophagy and regulating status of Treg cells in NOD mice. Int Immunopharmacol. 2024;143(Pt 3):113514.","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"861_CR92","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s10815-024-03327-y","volume":"42","author":"R Han","year":"2025","unstructured":"Han R, Zhu Y, Zhang X, Liu X, Xia Y, Ye E, La X, Ding J. Upregulation of PD-L1 contributes to improving the apoptosis of granulosa cells via the PI3K\/AKT pathway in PCOS. J Assist Reprod Genet. 2025;42(2):611\u201325.","journal-title":"J Assist Reprod Genet"}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-026-00861-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00861-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00861-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T04:50:06Z","timestamp":1788324606000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13062-026-00861-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":92,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["861"],"URL":"https:\/\/doi.org\/10.1186\/s13062-026-00861-w","relation":{},"ISSN":["1745-6150"],"issn-type":[{"value":"1745-6150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"assertion":[{"value":"25 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal procedures were conducted in accordance with protocols approved by Clinical Research and Laboratory Animal Ethics Committee of Sun Yat-sen University first Affiliated Hospital (Approval No. 2024-178) and conformed to the Guide for the Care and Use of Laboratory Animals published by the US National institutes of Health. This study was approved by the ethics committee of Sun Yat-sen University first Affiliated Hospital (Approval No. [2020]256) and conducted in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have read and approved the manuscript for submission.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"159"}}